Related Experiment Video
Updated: Apr 3, 2026

06:26
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
1.1K
MASH-GA: a manually curated cross-species transcriptomic database for metabolic-associated steatohepatitis
Yong Wang1,2,3, Ke Ding1,2,3, Beicheng Sun1,2,3
1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Summary
Metabolic dysfunction-associated steatohepatitis (MASH) is a growing liver disease concern. MASH-GA is the first database integrating human and mouse transcriptomic data for MASH research.
Area of Science:
- Hepatology
- Metabolic Disease Research
- Systems Biology
- Genomics
Background:
- Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease linked to metabolic dysregulation.
- It is a primary driver of liver failure and transplantation globally.
- A lack of centralized, accessible transcriptomic data hinders MASH research.
Purpose of the Study:
- To develop the first comprehensive, cross-species transcriptomic database for MASH research.
- To provide a centralized platform for integrating and analyzing human and mouse MASH data.
- To facilitate reproducible research and discovery in MASH.
Main Methods:
- Systematic integration of 45 human transcriptomic datasets (2740 samples) and 126 mouse datasets (1950 samples).
- Development of MASH-GA (MASH-Genomic Atlas) database with features like WGCNA, cross-model comparison, and interactive visualizations.
- Separate, intuitive modules for human and mouse data exploration.
Main Results:
- MASH-GA is the first and only database integrating transcriptomic data across human cohorts and mouse models for MASH.
- The platform offers advanced analytical tools including WGCNA, cross-model classification, and multigene correlation analysis.
- Standardized, multicohort, cross-species data enables robust exploration and identification of regulatory modules.
Conclusions:
- MASH-GA serves as a valuable, unique resource for the fatty liver research community.
- It empowers researchers to conduct reproducible data exploration and informed model selection.
- The database aids in identifying key regulatory modules relevant to MASH pathogenesis and treatment.